These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9619390)

  • 1. Post-ERCP pancreatitis and hyperamylasaemia: the role of operative and patient factors.
    Dickinson RJ; Davies S
    Eur J Gastroenterol Hepatol; 1998 May; 10(5):423-8. PubMed ID: 9619390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperamylasaemia and acute pancreatitis following endoscopic retrograde cholangiopancreatography.
    LaFerla G; Gordon S; Archibald M; Murray WR
    Pancreas; 1986; 1(2):160-3. PubMed ID: 2437564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil activation and hyperamylasaemia after endoscopic retrograde cholangiopancreatography: potential role for the leukocyte in the pathogenesis of acute pancreatitis.
    Mann DV; Kalu P; Foulds S; Edwards R; Glazer G
    Endoscopy; 2001 May; 33(5):448-53. PubMed ID: 11396766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
    Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
    Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the 4-hour Post-ERCP amylase level to predict post-ERCP pancreatitis.
    Sutton VR; Hong MK; Thomas PR
    JOP; 2011 Jul; 12(4):372-6. PubMed ID: 21737899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis.
    Testoni PA; Mariani A; Masci E; Curioni S
    Dig Liver Dis; 2006 Aug; 38(8):588-95. PubMed ID: 16731060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of post-endoscopic retrograde-cholangiopancreatography/sphincterotomy pancreatitis depends upon definition criteria.
    Testoni PA; Bagnolo F; Natale C; Primignani M
    Dig Liver Dis; 2000; 32(5):412-8. PubMed ID: 11030187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of pancreatitis following endoscopic retrograde cholangiopancreatography by the 4-h post procedure amylase level.
    Thomas PR; Sengupta S
    J Gastroenterol Hepatol; 2001 Aug; 16(8):923-6. PubMed ID: 11555108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
    Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
    Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study.
    Testoni PA; Mariani A; Giussani A; Vailati C; Masci E; Macarri G; Ghezzo L; Familiari L; Giardullo N; Mutignani M; Lombardi G; Talamini G; Spadaccini A; Briglia R; Piazzi L;
    Am J Gastroenterol; 2010 Aug; 105(8):1753-61. PubMed ID: 20372116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting post-endoscopic retrograde cholangiopancreatography pancreatitis using the 4-h serum lipase level.
    Papachristos A; Howard T; Thomson BN; Thomas PR
    ANZ J Surg; 2018 Jan; 88(1-2):82-86. PubMed ID: 27457275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure.
    Ito K; Fujita N; Noda Y; Kobayashi G; Horaguchi J; Takasawa O; Obana T
    World J Gastroenterol; 2007 Jul; 13(28):3855-60. PubMed ID: 17657841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for complications after performance of ERCP.
    Vandervoort J; Soetikno RM; Tham TC; Wong RC; Ferrari AP; Montes H; Roston AD; Slivka A; Lichtenstein DR; Ruymann FW; Van Dam J; Hughes M; Carr-Locke DL
    Gastrointest Endosc; 2002 Nov; 56(5):652-6. PubMed ID: 12397271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels.
    Lee YK; Yang MJ; Kim SS; Noh CK; Cho HJ; Lim SG; Hwang JC; Yoo BM; Kim JH
    J Korean Med Sci; 2017 Nov; 32(11):1814-1819. PubMed ID: 28960034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of trypsinogen-2 levels as an early diagnostic for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Kobayashi K; Sasaki T; Serikawa M; Inoue M; Itsuki H; Chayama K
    Pancreas; 2011 Nov; 40(8):1206-10. PubMed ID: 21792081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the laparoscopic-endoscopic approach, the so-called "rendezvous" technique, in cholecystocholedocholithiasis: a valid method in cases with patient-related risk factors for post-ERCP pancreatitis.
    Lella F; Bagnolo F; Rebuffat C; Scalambra M; Bonassi U; Colombo E
    Surg Endosc; 2006 Mar; 20(3):419-23. PubMed ID: 16424987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the urinary trypsinogen-2 dip stick test in early diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography.
    Sankaralingam S; Wesen C; Barawi M; Galera R; Lloyd L
    Surg Endosc; 2007 Aug; 21(8):1312-5. PubMed ID: 17332967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6, IL-10 and TNFα do not improve early detection of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: a prospective cohort study.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Mora J; Vidal S; Díez X; Torras X; Sainz S; Villanueva C; Farré A; Guarner-Argente C; Guarner C
    Sci Rep; 2016 Sep; 6():33492. PubMed ID: 27642079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study.
    Ito K; Fujita N; Kanno A; Matsubayashi H; Okaniwa S; Nakahara K; Suzuki K; Enohara R;
    Intern Med; 2011; 50(24):2927-32. PubMed ID: 22185981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.